Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $128 | $134 | $177 | $253 |
| Short-Term Investments | $25 | $72 | $247 | $298 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $8 | $20 | $7 |
| Total Curr. Assets | $161 | $214 | $444 | $558 |
| Property Plant & Equip (Net) | $135 | $146 | $159 | $162 |
| Goodwill | $141 | $141 | $141 | $141 |
| Intangibles | $59 | $59 | $59 | $59 |
| Long-Term Investments | $0 | $0 | $10 | $196 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $6 | $9 | $14 |
| Total NC Assets | $340 | $352 | $378 | $571 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $501 | $565 | $823 | $1,129 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $3 | $2 |
| Short-Term Debt | $13 | $13 | $12 | $9 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $28 | $47 | $96 | $88 |
| Total Curr. Liab. | $45 | $64 | $112 | $99 |
| LT Debt | $82 | $91 | $96 | $102 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $123 | $122 | $116 | $200 |
| Total NC Liab. | $205 | $213 | $212 | $302 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $94 | $104 | $108 | $111 |
| Total Liabilities | $251 | $278 | $323 | $401 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,605 | -$1,338 | -$1,055 | -$785 |
| AOCI | $0 | -$0 | -$4 | -$1 |
| Other Equity | $1,855 | $1,626 | $1,558 | $1,515 |
| Total Equity | $251 | $288 | $499 | $729 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $501 | $565 | $823 | $1,129 |
| Net Debt | -$33 | -$29 | -$69 | -$142 |